ID   DHB1_HUMAN              Reviewed;         328 AA.
AC   P14061; B3KXS1; Q2M2L8;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   10-MAY-2017, entry version 189.
DE   RecName: Full=Estradiol 17-beta-dehydrogenase 1;
DE            EC=1.1.1.62;
DE   AltName: Full=17-beta-hydroxysteroid dehydrogenase type 1;
DE            Short=17-beta-HSD 1;
DE   AltName: Full=20 alpha-hydroxysteroid dehydrogenase;
DE            Short=20-alpha-HSD;
DE   AltName: Full=E2DH;
DE   AltName: Full=Placental 17-beta-hydroxysteroid dehydrogenase;
DE   AltName: Full=Short chain dehydrogenase/reductase family 28C member 1;
GN   Name=HSD17B1; Synonyms=E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-313.
RC   TISSUE=Placenta;
RX   PubMed=2846351; DOI=10.1016/0014-5793(88)80548-9;
RA   Peltoketo H., Isomaa V., Maeentausta O., Vihko R.;
RT   "Complete amino acid sequence of human placental 17 beta-
RT   hydroxysteroid dehydrogenase deduced from cDNA.";
RL   FEBS Lett. 239:73-77(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-313.
RC   TISSUE=Placenta;
RX   PubMed=2779584; DOI=10.1210/mend-3-8-1301;
RA   Luu-The V., Labrie C., Zhao H.F., Couet J., Lachance Y., Simard J.,
RA   Leblanc G., Labrie F.;
RT   "Characterization of cDNAs for human estradiol 17 beta-dehydrogenase
RT   and assignment of the gene to chromosome 17: evidence of two mRNA
RT   species with distinct 5'-termini in human placenta.";
RL   Mol. Endocrinol. 3:1301-1309(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-313.
RX   PubMed=2330005; DOI=10.1210/mend-4-2-268;
RA   Luu-The V., Labrie C., Simard J., Lachance Y., Zhao H.F., Couet J.,
RA   Leblanc G., Labrie F.;
RT   "Structure of two in tandem human 17 beta-hydroxysteroid dehydrogenase
RT   genes.";
RL   Mol. Endocrinol. 4:268-275(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-313.
RX   PubMed=2197970; DOI=10.1111/j.1749-6632.1990.tb34281.x;
RA   Luu-The V., Labrie C., Zhao H.F., Couet J., Lachance Y., Simard J.,
RA   Cote J., Leblanc G., Lagace L., Berube D., Gagne R., Labrie F.;
RT   "Purification, cloning, complementary DNA structure, and predicted
RT   amino acid sequence of human estradiol 17 beta-dehydrogenase.";
RL   Ann. N. Y. Acad. Sci. 595:40-52(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-313.
RX   PubMed=1327779; DOI=10.1111/j.1432-1033.1992.tb17310.x;
RA   Peltoketo H.E., Isomma V., Vihko R.;
RT   "Genomic organization and DNA sequences of human 17 beta-
RT   hydroxysteroid dehydrogenase genes and flanking regions. Localization
RT   of multiple Alu sequences and putative cis-acting elements.";
RL   Eur. J. Biochem. 209:459-466(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-313.
RA   Shen Y., Gibbs R.A.;
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-313.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-313.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-313.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-6.
RX   PubMed=5045524; DOI=10.1021/bi00764a023;
RA   Burns D.J.W., Engel L.L., Bethune J.L.;
RT   "Amino acid composition and subunit structure. Human placental 17 -
RT   estradiol dehydrogenase.";
RL   Biochemistry 11:2699-2703(1972).
RN   [12]
RP   PROTEIN SEQUENCE OF 52-68.
RX   PubMed=4719204; DOI=10.1016/0014-5793(73)80554-X;
RA   Nicholas J.C., Harris J.I.;
RT   "Human placental 17 -oestradiol dehydrogenase. Sequence of a tryptic
RT   peptide containing an essential cysteine.";
RL   FEBS Lett. 29:173-176(1973).
RN   [13]
RP   PROTEIN SEQUENCE OF 205-224.
RX   PubMed=3456799; DOI=10.1021/bi00351a019;
RA   Murdock G.L., Chin C.-C., Warren J.C.;
RT   "Human placental estradiol 17 beta-dehydrogenase: sequence of a
RT   histidine-bearing peptide in the catalytic region.";
RL   Biochemistry 25:641-646(1986).
RN   [14]
RP   PROTEIN SEQUENCE OF 220-224.
RX   PubMed=6578212;
RA   Murdock G.L., Chin C.C., Offord R.E., Bradshaw R.A., Warren J.C.;
RT   "Human placental estradiol 17 beta-dehydrogenase. Identification of a
RT   single histidine residue affinity-labeled by both 3-
RT   bromoacetoxyestrone and 12 beta-bromoacetoxy-4-estrene-3,17-dione.";
RL   J. Biol. Chem. 258:11460-11464(1983).
RN   [15]
RP   SIMILARITY TO SHORT CHAIN DEHYDROGENASES.
RX   PubMed=2547159; DOI=10.1210/mend-3-5-881;
RA   Baker M.E.;
RT   "Human placental 17 beta-hydroxysteroid dehydrogenase is homologous to
RT   NodG protein of Rhizobium meliloti.";
RL   Mol. Endocrinol. 3:881-884(1989).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS).
RX   PubMed=7663947; DOI=10.1016/S0969-2126(01)00183-6;
RA   Ghosh D., Pletnev V.Z., Zhu D.W., Wawrzak Z., Duax W.L., Pangborn W.,
RA   Labrie F., Lin S.-X.;
RT   "Structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase at
RT   2.20-A resolution.";
RL   Structure 3:503-513(1995).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   PubMed=8756321; DOI=10.1038/nsb0896-665;
RA   Azzi A., Rehse P.H., Zhu D.W., Campbell R.L., Labrie F., Lin S.X.;
RT   "Crystal structure of human estrogenic 17 beta-hydroxysteroid
RT   dehydrogenase complexed with 17 beta-estradiol.";
RL   Nat. Struct. Biol. 3:665-668(1996).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND
RP   NADP.
RX   PubMed=8805577; DOI=10.1016/S0969-2126(96)00098-6;
RA   Breton R., Housset D., Mazza C., Fontecilla-Camps J.-C.;
RT   "The structure of a complex of human 17beta-hydroxysteroid
RT   dehydrogenase with estradiol and NADP+ identifies two principal
RT   targets for the design of inhibitors.";
RL   Structure 4:905-915(1996).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=9525918; DOI=10.1074/jbc.273.14.8145;
RA   Mazza C., Breton R., Housset D., Fontecilla-Camps J.-C.;
RT   "Unusual charge stabilization of NADP+ in 17beta-hydroxysteroid
RT   dehydrogenase.";
RL   J. Biol. Chem. 273:8145-8152(1998).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=9927655; DOI=10.1073/pnas.96.3.840;
RA   Sawicki M.W., Erman M., Puranen T., Vihko P., Ghosh D.;
RT   "Structure of the ternary complex of human 17beta-hydroxysteroid
RT   dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one
RT   (equilin) and NADP+.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:840-845(1999).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.24 ANGSTROMS) OF 39-328, AND MUTAGENESIS OF
RP   LEU-150.
RX   PubMed=10625652; DOI=10.1074/jbc.275.2.1105;
RA   Han Q., Campbell R.L., Gangloff A., Huang Y.-W., Lin S.-X.;
RT   "Dehydroepiandrosterone and dihydrotestosterone recognition by human
RT   estrogenic 17beta-hydroxysteroid dehydrogenase. C-18/c-19 steroid
RT   discrimination and enzyme-induced strain.";
RL   J. Biol. Chem. 275:1105-1111(2000).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS).
RX   PubMed=12223444; DOI=10.1096/fj.02-0026fje;
RA   Qiu W., Campbell R.L., Gangloff A., Dupuis P., Boivin R.P.,
RA   Tremblay M.R., Poirier D., Lin S.X.;
RT   "A concerted, rational design of type 1 17beta-hydroxysteroid
RT   dehydrogenase inhibitors: estradiol-adenosine hybrids with high
RT   affinity.";
RL   FASEB J. 16:1829-1831(2002).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS).
RX   PubMed=12490543; DOI=10.1096/fj.02-0397fje;
RA   Gangloff A., Shi R., Nahoum V., Lin S.X.;
RT   "Pseudo-symmetry of C19 steroids, alternative binding orientations,
RT   and multispecificity in human estrogenic 17beta-hydroxysteroid
RT   dehydrogenase.";
RL   FASEB J. 17:274-276(2003).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS).
RX   PubMed=14966133; DOI=10.1074/jbc.M313156200;
RA   Shi R., Lin S.X.;
RT   "Cofactor hydrogen bonding onto the protein main chain is conserved in
RT   the short chain dehydrogenase/reductase family and contributes to
RT   nicotinamide orientation.";
RL   J. Biol. Chem. 279:16778-16785(2004).
RN   [25]
RP   VARIANTS VAL-238 AND SER-313.
RX   PubMed=8389226; DOI=10.1093/hmg/2.4.479;
RA   Normand T., Narod S., Labrie F., Simard J.;
RT   "Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid
RT   dehydrogenase II gene at the EDH17B2 locus on 17q11-q21.";
RL   Hum. Mol. Genet. 2:479-483(1993).
CC   -!- FUNCTION: Favors the reduction of estrogens and androgens. Also
CC       has 20-alpha-HSD activity. Uses preferentially NADH.
CC   -!- CATALYTIC ACTIVITY: 17-beta-estradiol + NAD(P)(+) = estrone +
CC       NAD(P)H.
CC   -!- PATHWAY: Steroid biosynthesis; estrogen biosynthesis.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:8805577}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=HSD17B1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X13440; CAA31792.1; -; mRNA.
DR   EMBL; M36263; AAA35600.1; -; mRNA.
DR   EMBL; M27138; AAB16941.1; -; Genomic_DNA.
DR   EMBL; M84472; AAB16942.1; -; Genomic_DNA.
DR   EMBL; U34879; AAD05019.1; -; Genomic_DNA.
DR   EMBL; AK127832; BAG54583.1; -; mRNA.
DR   EMBL; AC067852; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471152; EAW60836.1; -; Genomic_DNA.
DR   EMBL; BC104752; AAI04753.1; -; mRNA.
DR   EMBL; BC111935; AAI11936.1; -; mRNA.
DR   CCDS; CCDS11428.1; -.
DR   PIR; A36081; DEHUE7.
DR   RefSeq; NP_000404.2; NM_000413.3.
DR   UniGene; Hs.654385; -.
DR   UniGene; Hs.655222; -.
DR   PDB; 1A27; X-ray; 1.90 A; A=2-290.
DR   PDB; 1BHS; X-ray; 2.20 A; A=2-328.
DR   PDB; 1DHT; X-ray; 2.24 A; A=2-328.
DR   PDB; 1EQU; X-ray; 3.00 A; A/B=2-328.
DR   PDB; 1FDS; X-ray; 1.70 A; A=2-328.
DR   PDB; 1FDT; X-ray; 2.20 A; A=2-328.
DR   PDB; 1FDU; X-ray; 2.70 A; A/B/C/D=2-328.
DR   PDB; 1FDV; X-ray; 3.10 A; A/B/C/D=2-328.
DR   PDB; 1FDW; X-ray; 2.70 A; A=2-328.
DR   PDB; 1I5R; X-ray; 1.60 A; A=2-328.
DR   PDB; 1IOL; X-ray; 2.30 A; A=2-328.
DR   PDB; 1JTV; X-ray; 1.54 A; A=2-328.
DR   PDB; 1QYV; X-ray; 1.81 A; A=2-328.
DR   PDB; 1QYW; X-ray; 1.63 A; A=2-328.
DR   PDB; 1QYX; X-ray; 1.89 A; A=2-328.
DR   PDB; 3DEY; X-ray; 1.70 A; X=2-328.
DR   PDB; 3DHE; X-ray; 2.30 A; A=2-328.
DR   PDB; 3HB4; X-ray; 2.21 A; X=2-328.
DR   PDB; 3HB5; X-ray; 2.00 A; X=2-328.
DR   PDB; 3KLM; X-ray; 1.70 A; X=2-328.
DR   PDB; 3KLP; X-ray; 2.50 A; X=2-328.
DR   PDB; 3KM0; X-ray; 2.30 A; A/B=2-328.
DR   PDBsum; 1A27; -.
DR   PDBsum; 1BHS; -.
DR   PDBsum; 1DHT; -.
DR   PDBsum; 1EQU; -.
DR   PDBsum; 1FDS; -.
DR   PDBsum; 1FDT; -.
DR   PDBsum; 1FDU; -.
DR   PDBsum; 1FDV; -.
DR   PDBsum; 1FDW; -.
DR   PDBsum; 1I5R; -.
DR   PDBsum; 1IOL; -.
DR   PDBsum; 1JTV; -.
DR   PDBsum; 1QYV; -.
DR   PDBsum; 1QYW; -.
DR   PDBsum; 1QYX; -.
DR   PDBsum; 3DEY; -.
DR   PDBsum; 3DHE; -.
DR   PDBsum; 3HB4; -.
DR   PDBsum; 3HB5; -.
DR   PDBsum; 3KLM; -.
DR   PDBsum; 3KLP; -.
DR   PDBsum; 3KM0; -.
DR   DisProt; DP00023; -.
DR   ProteinModelPortal; P14061; -.
DR   SMR; P14061; -.
DR   BioGrid; 109525; 2.
DR   IntAct; P14061; 1.
DR   STRING; 9606.ENSP00000466799; -.
DR   BindingDB; P14061; -.
DR   ChEMBL; CHEMBL3181; -.
DR   DrugBank; DB03461; 2'-Monophosphoadenosine 5'-Diphosphoribose.
DR   DrugBank; DB01536; 4-Androstenedione.
DR   DrugBank; DB01561; Androstanedione.
DR   DrugBank; DB02901; Dihydrotestosterone.
DR   DrugBank; DB02323; EM-1745.
DR   DrugBank; DB02187; Equilin.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB01708; Prasterone.
DR   SwissLipids; SLP:000001218; -.
DR   SwissPalm; P14061; -.
DR   BioMuta; HSD17B1; -.
DR   DMDM; 313104233; -.
DR   PaxDb; P14061; -.
DR   PeptideAtlas; P14061; -.
DR   PRIDE; P14061; -.
DR   Ensembl; ENST00000585807; ENSP00000466799; ENSG00000108786.
DR   GeneID; 3292; -.
DR   KEGG; hsa:3292; -.
DR   UCSC; uc002hzw.4; human.
DR   CTD; 3292; -.
DR   DisGeNET; 3292; -.
DR   GeneCards; HSD17B1; -.
DR   H-InvDB; HIX0202506; -.
DR   HGNC; HGNC:5210; HSD17B1.
DR   HPA; HPA021032; -.
DR   HPA; HPA065296; -.
DR   MIM; 109684; gene.
DR   neXtProt; NX_P14061; -.
DR   OpenTargets; ENSG00000108786; -.
DR   PharmGKB; PA29478; -.
DR   eggNOG; KOG1205; Eukaryota.
DR   eggNOG; COG1028; LUCA.
DR   GeneTree; ENSGT00870000136396; -.
DR   HOVERGEN; HBG014077; -.
DR   InParanoid; P14061; -.
DR   KO; K00044; -.
DR   PhylomeDB; P14061; -.
DR   BRENDA; 1.1.1.62; 2681.
DR   Reactome; R-HSA-193144; Estrogen biosynthesis.
DR   Reactome; R-HSA-2453902; The canonical retinoid cycle in rods (twilight vision).
DR   SABIO-RK; P14061; -.
DR   UniPathway; UPA00769; -.
DR   EvolutionaryTrace; P14061; -.
DR   GeneWiki; HSD17B1; -.
DR   GenomeRNAi; 3292; -.
DR   PRO; PR:P14061; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108786; -.
DR   CleanEx; HS_HSD17B1; -.
DR   ExpressionAtlas; P14061; baseline and differential.
DR   Genevisible; P14061; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0003824; F:catalytic activity; TAS:ProtInc.
DR   GO; GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IDA:CAFA.
DR   GO; GO:1903924; F:estradiol binding; IDA:CAFA.
DR   GO; GO:0070401; F:NADP+ binding; IMP:CAFA.
DR   GO; GO:0005496; F:steroid binding; IDA:CAFA.
DR   GO; GO:0006703; P:estrogen biosynthetic process; TAS:Reactome.
DR   GO; GO:0008210; P:estrogen metabolic process; TAS:ProtInc.
DR   GO; GO:0006694; P:steroid biosynthetic process; TAS:ProtInc.
DR   InterPro; IPR011348; 17beta_DH.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PIRSF; PIRSF000095; 17beta-HSD; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Lipid biosynthesis; Lipid metabolism; NADP; Oxidoreductase;
KW   Polymorphism; Reference proteome; Steroid biosynthesis.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:5045524}.
FT   CHAIN         2    328       Estradiol 17-beta-dehydrogenase 1.
FT                                /FTId=PRO_0000054567.
FT   NP_BIND      10     38       NADP. {ECO:0000269|PubMed:8805577}.
FT   ACT_SITE    156    156       Proton acceptor.
FT   BINDING      66     66       NADP. {ECO:0000269|PubMed:8805577}.
FT   BINDING     143    143       Substrate. {ECO:0000269|PubMed:8805577}.
FT   BINDING     160    160       NADP. {ECO:0000269|PubMed:8805577}.
FT   VARIANT     238    238       A -> V (in dbSNP:rs147402365).
FT                                {ECO:0000269|PubMed:8389226}.
FT                                /FTId=VAR_006951.
FT   VARIANT     313    313       G -> S (in dbSNP:rs605059).
FT                                {ECO:0000269|PubMed:1327779,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2197970,
FT                                ECO:0000269|PubMed:2330005,
FT                                ECO:0000269|PubMed:2779584,
FT                                ECO:0000269|PubMed:2846351,
FT                                ECO:0000269|PubMed:8389226,
FT                                ECO:0000269|Ref.6, ECO:0000269|Ref.9}.
FT                                /FTId=VAR_006952.
FT   MUTAGEN     150    150       L->V: Alters substrate specificity.
FT                                {ECO:0000269|PubMed:10625652}.
FT   CONFLICT      3      3       R -> E (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND        4      9       {ECO:0000244|PDB:1JTV}.
FT   HELIX        14     24       {ECO:0000244|PDB:1JTV}.
FT   STRAND       31     38       {ECO:0000244|PDB:1JTV}.
FT   HELIX        40     42       {ECO:0000244|PDB:1JTV}.
FT   HELIX        44     52       {ECO:0000244|PDB:1JTV}.
FT   STRAND       59     64       {ECO:0000244|PDB:1JTV}.
FT   HELIX        70     78       {ECO:0000244|PDB:1JTV}.
FT   STRAND       86     90       {ECO:0000244|PDB:1JTV}.
FT   HELIX       100    102       {ECO:0000244|PDB:1JTV}.
FT   HELIX       105    115       {ECO:0000244|PDB:1JTV}.
FT   HELIX       117    133       {ECO:0000244|PDB:1JTV}.
FT   STRAND      136    143       {ECO:0000244|PDB:1JTV}.
FT   HELIX       144    146       {ECO:0000244|PDB:1JTV}.
FT   HELIX       154    174       {ECO:0000244|PDB:1JTV}.
FT   HELIX       175    177       {ECO:0000244|PDB:1JTV}.
FT   STRAND      179    186       {ECO:0000244|PDB:1JTV}.
FT   STRAND      189    192       {ECO:0000244|PDB:1A27}.
FT   TURN        193    196       {ECO:0000244|PDB:1A27}.
FT   HELIX       201    206       {ECO:0000244|PDB:1JTV}.
FT   HELIX       210    230       {ECO:0000244|PDB:1JTV}.
FT   HELIX       234    246       {ECO:0000244|PDB:1JTV}.
FT   STRAND      252    256       {ECO:0000244|PDB:1JTV}.
FT   STRAND      258    260       {ECO:0000244|PDB:1EQU}.
FT   HELIX       261    269       {ECO:0000244|PDB:1JTV}.
FT   HELIX       274    285       {ECO:0000244|PDB:1JTV}.
SQ   SEQUENCE   328 AA;  34950 MW;  5B5C8909F9120832 CRC64;
     MARTVVLITG CSSGIGLHLA VRLASDPSQS FKVYATLRDL KTQGRLWEAA RALACPPGSL
     ETLQLDVRDS KSVAAARERV TEGRVDVLVC NAGLGLLGPL EALGEDAVAS VLDVNVVGTV
     RMLQAFLPDM KRRGSGRVLV TGSVGGLMGL PFNDVYCASK FALEGLCESL AVLLLPFGVH
     LSLIECGPVH TAFMEKVLGS PEEVLDRTDI HTFHRFYQYL AHSKQVFREA AQNPEEVAEV
     FLTALRAPKP TLRYFTTERF LPLLRMRLDD PSGSNYVTAM HREVFGDVPA KAEAGAEAGG
     GAGPGAEDEA GRGAVGDPEL GDPPAAPQ
//
